Center for Scientific Review; Notice of Closed Meetings, 51536 [2024-13359]
Download as PDF
<![CDATA[
51536
Federal Register / Vol. 89, No. 118 / Tuesday, June 18, 2024 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Type of interview
Total annual
responses
Average burden
per response
Total
hours
In-Person Individual In-depth Interviews .................
In-depth Interview Screener .....................................
Focus Group Screener ............................................
Focus Group Discussion ..........................................
Discussion Board Screener .....................................
Discussion Board Participation ................................
4,500
22,500
56,000
252,000
8,000
100
1
1
1
1
1
1
4,500
22,500
56,000
252,000
8,000
100
1 ................................
0.083 (5 minutes) ......
0.25 (15 minutes) ......
1.5 .............................
0.083 (5 minutes) ......
1.5 .............................
4,500
1,875
14,000
378,000
667
150
Total ..................................................................
........................
........................
........................
....................................
399,192
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Our estimated burden for the
information collection reflects an
overall increase of 384,258 hours and a
corresponding increase of 314,926
responses. We attribute this adjustment
to the number of study responses used
during the current approval and now
estimated for the next 3 years. A greater
number of qualitative studies will be
conducted over the next 3 years due to
the need to develop new creative
messages and content. Recent years
have seen a dramatic change in media.
With the shift to digital media, FDA
must adapt to communicate effectively
in a digital environment. As digital
tobacco use prevention/interventions
are still in their infancy, we must better
understand the types of digital channels
available. To impact public health
outcomes, we need to understand how
to reach our intended audience. New
foundational studies are needed
(including those on digital metrics,
measurement, and implementation). As
a result, we have adjusted our burden
estimate and revised the number of
respondents to the information
collection.
Dated: June 13, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–13386 Filed 6–17–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
17:57 Jun 17, 2024
Jkt 262001
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Social and Community Influences
Across the Lifecourse.
Date: July 10, 2024.
Time: 10:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia E. Ortenberg, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
Bethesda, MD 20892, 301–827–7189,
femiaee@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–23–
318: Mobile Health: Technology and
Outcomes in Low and Middle Income
Countries Panel A (R21/R33—Clinical Trial
Optional).
Date: July 11–12, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria De Jesus Diaz Perez,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000G,
Bethesda, MD 20892, (301) 496–4227,
diazperezm2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuroimmune and Neuroinflammation
involved in Neurodegenerative Disorders.
Date: July 11–12, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariam Zaka, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00045
Fmt 4703
Sfmt 9990
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1009J,
Bethesda, MD 20892, (301) 435–1042,
zakam2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Clinical Informatics and Data Analytics.
Date: July 11–12, 2024.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
Bethesda, MD 20892, (301) 827–4446,
bellingerjd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Thrombosis and Blood Cells.
Date: July 12, 2024.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bukhtiar H. Shah, DVM,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120,
MSC 7802, Bethesda, MD 20892, (301) 806–
7314, shahb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 13, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–13359 Filed 6–17–24; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\18JNN1.SGM
18JNN1
]]>Agencies
[Federal Register Volume 89, Number 118 (Tuesday, June 18, 2024)]
[Notices]
[Page 51536]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13359]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Social and Community Influences Across the
Lifecourse.
Date: July 10, 2024.
Time: 10:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia E. Ortenberg, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108, Bethesda, MD 20892, 301-
827-7189, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-23-318: Mobile Health: Technology and Outcomes in Low and
Middle Income Countries Panel A (R21/R33--Clinical Trial Optional).
Date: July 11-12, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria De Jesus Diaz Perez, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000G, Bethesda, MD 20892, (301)
496-4227, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neuroimmune and Neuroinflammation involved in
Neurodegenerative Disorders.
Date: July 11-12, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariam Zaka, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1009J, Bethesda, MD 20892, (301) 435-1042,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Clinical Informatics and Data Analytics.
Date: July 11-12, 2024.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, (301)
827-4446, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Thrombosis and Blood Cells.
Date: July 12, 2024.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bukhtiar H. Shah, DVM, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120, MSC 7802, Bethesda, MD
20892, (301) 806-7314, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 13, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-13359 Filed 6-17-24; 8:45 am]
BILLING CODE 4140-01-P
